PL374954A1 - Zastosowanie antagonistów oksytocyny lub antagonistów oksytocyny i wazopresyny lub antagonistów wazopresyny do wytwarzania leków stosowanych podczas procedur wspomaganego rozrodu - Google Patents
Zastosowanie antagonistów oksytocyny lub antagonistów oksytocyny i wazopresyny lub antagonistów wazopresyny do wytwarzania leków stosowanych podczas procedur wspomaganego rozroduInfo
- Publication number
- PL374954A1 PL374954A1 PL374954A PL37495405A PL374954A1 PL 374954 A1 PL374954 A1 PL 374954A1 PL 374954 A PL374954 A PL 374954A PL 37495405 A PL37495405 A PL 37495405A PL 374954 A1 PL374954 A1 PL 374954A1
- Authority
- PL
- Poland
- Prior art keywords
- antagonists
- oxitocin
- oxytocin
- vasopressin
- aided
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 2
- 101800000989 Oxytocin Proteins 0.000 title 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 title 1
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 title 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 title 1
- 108010004977 Vasopressins Proteins 0.000 title 1
- 102000002852 Vasopressins Human genes 0.000 title 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 title 1
- 229960001723 oxytocin Drugs 0.000 title 1
- 229960003726 vasopressin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL374954A PL374954A1 (pl) | 2005-05-10 | 2005-05-10 | Zastosowanie antagonistów oksytocyny lub antagonistów oksytocyny i wazopresyny lub antagonistów wazopresyny do wytwarzania leków stosowanych podczas procedur wspomaganego rozrodu |
| JP2008511075A JP4762308B2 (ja) | 2005-05-10 | 2006-05-10 | 生殖補助におけるオキシトシンのおよび／またはバソプレシンの拮抗薬の使用 |
| MX2007014022A MX2007014022A (es) | 2005-05-10 | 2006-05-10 | Uso de antagonistas de oxitocina y/o vasopresina en la reproduccion asistida. |
| SI200631039T SI1879572T1 (sl) | 2005-05-10 | 2006-05-10 | Uporaba antagonistov oksitocina in/ali vazopresina pri asistirani reprodukciji |
| PCT/PL2006/000029 WO2006121362A2 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| PT06747719T PT1879572E (pt) | 2005-05-10 | 2006-05-10 | Uso de antagonistas de oxitocina e/ou vasopressina na reprodução assistida |
| CA2605923A CA2605923C (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin |
| DK06747719.0T DK1879572T3 (da) | 2005-05-10 | 2006-05-10 | Anvendelse af antagonister af oxytocin og/eller vasopressin i kunstig befrugtning |
| EP06747719A EP1879572B1 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| DE602006021736T DE602006021736D1 (de) | 2005-05-10 | 2006-05-10 | Verwendung von antagonisten von oxytocin und/oder vasopressin bei der assistierten fortpflanzung |
| AT06747719T ATE507830T1 (de) | 2005-05-10 | 2006-05-10 | Verwendung von antagonisten von oxytocin und/oder vasopressin bei der assistierten fortpflanzung |
| PL06747719T PL1879572T3 (pl) | 2005-05-10 | 2006-05-10 | Zastosowanie antagonistów oksytocyny i/lub wazopresyny we wspomaganym rozrodzie |
| ES06747719T ES2366130T3 (es) | 2005-05-10 | 2006-05-10 | Uso de antagonistas de oxitocina y/o vasopresina en reproducción asistida. |
| AU2006244693A AU2006244693B2 (en) | 2005-05-10 | 2006-05-10 | Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| NZ562409A NZ562409A (en) | 2005-05-10 | 2006-05-10 | Use of barusiban in assisted reproduction |
| CN2006800568367A CN101646436B (zh) | 2005-05-10 | 2006-05-10 | 催产素和/或血管升压素的拮抗剂在辅助生殖中的应用 |
| KR1020077025706A KR100985449B1 (ko) | 2005-05-10 | 2006-05-10 | 옥시톡신 및/또는 바소프레신 길항제의 용도 |
| US11/914,049 US20080318847A1 (en) | 2005-05-10 | 2006-05-10 | Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction |
| RU2007140702/15A RU2385735C2 (ru) | 2005-05-10 | 2006-05-10 | Применение антагонистов окситоцина при вспомогательной репродукции |
| IL186595A IL186595A (en) | 2005-05-10 | 2007-10-11 | Use of Brosiban for the preparation of drugs to improve uterine absorption during supported fertility |
| NO20076328A NO340956B1 (no) | 2005-05-10 | 2007-12-10 | Anvendelse av antagonister for oksytocin og/eller vasopressin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL374954A PL374954A1 (pl) | 2005-05-10 | 2005-05-10 | Zastosowanie antagonistów oksytocyny lub antagonistów oksytocyny i wazopresyny lub antagonistów wazopresyny do wytwarzania leków stosowanych podczas procedur wspomaganego rozrodu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374954A1 true PL374954A1 (pl) | 2006-11-13 |
Family
ID=35999478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL374954A PL374954A1 (pl) | 2005-05-10 | 2005-05-10 | Zastosowanie antagonistów oksytocyny lub antagonistów oksytocyny i wazopresyny lub antagonistów wazopresyny do wytwarzania leków stosowanych podczas procedur wspomaganego rozrodu |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL374954A1 (pl) |
-
2005
- 2005-05-10 PL PL374954A patent/PL374954A1/pl not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1812030A4 (en) | ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF | |
| EP1786451A4 (en) | ANTIANGIOGENIC PEPTIDES AND METHOD FOR THEIR USE | |
| IL186959A0 (en) | Peptides and pharmaceutical compositions containing the same | |
| IL177125A0 (en) | Vertical nanotube semiconducteur device structures and methods of forming the same | |
| EP2043482A4 (en) | COSMETIC CONTAINER WITH AIR-CONDENSED STRUCTURE | |
| IL183583A0 (en) | Quinazoline derivatives and pharmaceutical compositions containing the same | |
| ZA200900204B (en) | Substituted piperidines that increase P53 activity and the uses thereof | |
| DE502004003234D1 (de) | Gegen missbrauch gesicherte darreichungsform | |
| DE502004004205D1 (de) | Gegen missbrauch gesicherte darreichungsform | |
| IL181524A (en) | Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs | |
| PL378135A1 (pl) | 2-Cyjanopirolopirymidyny i ich zastosowania w farmaceutykach | |
| IL183101A0 (en) | Use of cannabinoids in the manufacture of medicaments | |
| LT1901749T (lt) | Aerozoliniai fluorchinolinai ir jų naudojimas | |
| IL190055A0 (en) | Quinolines and their therapeutic use | |
| IL198364A0 (en) | Compositions comprising alphavirus or alphavirus replicon particles and methods of producing the same | |
| PL1894567T3 (pl) | Środki farmaceutyczne do podawania skojarzonego oraz ich zastosowanie | |
| IL203898A0 (en) | Cdca1 peptide and pharmaceutical agent comprising the same | |
| BRPI0816236A2 (pt) | Peptídeo cdh3 e agente medicinal contendo o mesmo | |
| IL182494A0 (en) | Non-peptide bradykinin antagonists and pharmaceutical composition therefrom | |
| IL193700A0 (en) | Medicaments and proteins | |
| EP1890677A4 (en) | PHARMACEUTICAL COMPOSITIONS AND THEIR USE | |
| IL177744A0 (en) | Aptamers and pharmaceutical compositions containing the same | |
| DE602005006062D1 (de) | Plättchenförmige Komposit-Partikeln und Kosmetika enthaltend die selben | |
| GB0516069D0 (en) | Pharmaceutical and use thereof | |
| IL192143A0 (en) | Alumina particles and methods of making the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |